We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$939M
AUM Growth
+$88.3M
Cap. Flow
+$12.8M
Cap. Flow %
1.36%
Top 10 Hldgs %
46.76%
Holding
55
New
Increased
27
Reduced
16
Closed

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$3.89M
2
NVO
Novo Nordisk
NVO
+$3.16M
3
CHRW icon
C.H. Robinson
CHRW
+$3.15M
4
IBM icon
IBM
IBM
+$3.01M
5
ORCL icon
Oracle
ORCL
+$2.89M

Top Sells

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$18M
2
ABT icon
Abbott
ABT
+$9.3M
3
NKE icon
Nike
NKE
+$815K
4
JNJ icon
Johnson & Johnson
JNJ
+$511K
5
GD icon
General Dynamics
GD
+$349K

Sector Composition

Rank Sector Weight
1 Technology 26.49%
2 Healthcare 20.56%
3 Consumer Staples 17.22%
4 Industrials 16.25%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
1
3M
MMM
$95B
$53.9M 5.74%
460,007
+17,817
+4% +$1.9M
ORCL icon
2
Oracle
ORCL
$420B
$49.3M 5.25%
1,289,049
+83,938
+7% +$2.89M
MSFT icon
3
Microsoft
MSFT
$3.72T
$48.5M 5.16%
1,295,156
+66,813
+5% +$2.43M
OMC icon
4
Omnicom Group
OMC
$23B
$45.7M 4.87%
615,052
+14,856
+2% +$1.02M
RTX icon
5
RTX Corp
RTX
$302B
$43.7M 4.65%
609,806
+38,526
+7% +$2.63M
MDT icon
6
Medtronic
MDT
$116B
$42.5M 4.53%
741,203
+19,575
+3% +$1.11M
WMT icon
7
Walmart Inc
WMT
$901B
$40.5M 4.32%
1,545,561
+79,299
+5% +$2.05M
PG icon
8
Procter & Gamble
PG
$338B
$38.9M 4.15%
478,348
+23,896
+5% +$1.95M
KO icon
9
Coca-Cola
KO
$374B
$38.5M 4.1%
933,185
+60,077
+7% +$2.37M
CSCO icon
10
Cisco
CSCO
$477B
$37.5M 3.99%
1,670,516
+100,664
+6% +$2.23M
BDX icon
11
Becton Dickinson
BDX
$49.4B
$37.2M 3.97%
345,498
+20,684
+6% +$2.14M
MCD icon
12
McDonald's
MCD
$193B
$36.8M 3.92%
379,413
+25,081
+7% +$2.41M
IBM icon
13
IBM
IBM
$222B
$35.7M 3.8%
198,938
+17,455
+10% +$3.01M
JNJ icon
14
Johnson & Johnson
JNJ
$636B
$34.3M 3.65%
374,101
-5,545
-1% -$511K
NKE icon
15
Nike
NKE
$61.4B
$31.8M 3.39%
809,254
-21,288
-3% -$815K
NVO
16
Novo Nordisk
NVO
$208B
$30.3M 3.22%
1,638,270
+181,350
+12% +$3.16M
AAPL icon
17
Apple
AAPL
$4.47T
$24.9M 2.65%
1,241,660
+25,368
+2% +$479K
CHRW icon
18
C.H. Robinson
CHRW
$17.2B
$23.3M 2.48%
399,843
+53,637
+15% +$3.15M
BRK.B icon
19
Berkshire Hathaway Class B
BRK.B
$1.12T
$20.5M 2.19%
173,232
+6,149
+4% +$711K
ACN icon
20
Accenture
ACN
$108B
$20.3M 2.16%
246,862
+51,472
+26% +$3.89M
TPR icon
21
Tapestry
TPR
$33.1B
$19.7M 2.1%
351,105
+18,797
+6% +$1.02M
VAR
22
DELISTED
Varian Medical Systems, Inc.
VAR
$19.2M 2.05%
282,154
+4,984
+2% +$332K
ADP icon
23
Automatic Data Processing
ADP
$108B
$19M 2.02%
267,547
-267,150
-50% -$18M
GD icon
24
General Dynamics
GD
$107B
$18.9M 2.01%
197,492
-3,907
-2% -$349K
SYK icon
25
Stryker
SYK
$134B
$17.6M 1.87%
234,019
-4,705
-2% -$343K

Similar funds

Saratoga Research & Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Saratoga Research & Investment Management held 55 positions worth $939M, up 10% from $851M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 0%. Saratoga Research & Investment Management opened no new positions and made no exits, leaving the 55-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management added most to Accenture in Q4 2013, an estimated $3.89M increase.
  • Saratoga Research & Investment Management's biggest Q4 2013 reduction was Automatic Data Processing, cutting an estimated $18M.
  • Saratoga Research & Investment Management's ten largest holdings make up 47% of its $939M portfolio in Q4 2013.
  • Saratoga Research & Investment Management opened 0 new positions and closed 0 in Q4 2013.
  • Saratoga Research & Investment Management's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Saratoga Research & Investment Management's 13F filing for Q4 2013, filed 18 Feb 2014.